The enantiomer separation of five nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, ketoprofen (KP) and naproxen (NX), which are included in The Japanese Pharmacopoeia 16th edition (JP16), was investigated by employing four kinds of 3 μm reversed-phase chiral columns (AD-3R, AS-3R, OD-3R and OJ-3R). Except for KP, the enantiomers of four NSAIDs were successfully separated by one of the four columns. Among five NSAIDs, only NX has been used as a single enantiomer (S-form, active form) in the clinical field (JP16); therefore, optical purity testing method of NX is required for its quality evaluation. Among four CSPs, the method was developed by using an AS-3R column, which showed good enantioselectivity for NX enantiomers. By optimizing the conditions, the resolution (Rs) of 2.55 was obtained for NX enantiomers within approximately 6 min. The minor enantiomer R-form eluted before the main active enantiomer S-form. Finally, the developed method was applied to the optical purity testing of NX active pharmaceutical ingredients (APIs), and its formulations (tablet and capsule). Other than the minor enantiomer (R-form, inactive form, 0.21 -0.78%), normal (not chiral) impurities at levels of 0.01 -0.3% were simultaneously separated and determined by the method, showing an excellent separation capability of the method for those impurities including the minor enantiomer. The content uniformity test of the NX tablet according to JP16 was also successfully performed by the method with the AS-3R column. Normal phase separation with two chiral columns (AD-H and OD-H) and capillary electrophoretic (CE) separation were also investigated for five NSAIDs enantiomers to discuss the enantioselectivity.
Introduction
The need and demand for the enantiomer separation of pharmaceuticals and agrochemicals are well established and documented. [1] [2] [3] [4] This is due to the different pharmaceutical activities of the enantiomers. In some cases, the opposite enantiomer shows toxicity. Therefore, the current ICH (International Conference on Harmonization) guideline for the new drug development Q6A, 5 requires the evaluating the minor enantiomer as one of the common (not chiral) impurities, due to great progress in the enantiomer separation sciences.
Among many techniques, chromatography has achieved a good status in enantiomer separation due to the wide variety of commercially available chiral stationary phases (CSPs). Cyclodextrins (CDs), proteins, antibiotics etc. have been successfully applied to CSPs as a chiral moeity. [1] [2] [3] [4] Especially, polysaccharide-based CSPs are popular due to their wide capability to separate enantiomers. According to papers, 6 -8 more than 80% of enantiomeric compounds have been successfully separated by these columns. Typically, normal-phase HPLC has been used for the separation. However, in the determination of drugs in biological samples, such as serum and urine, and the quality or impurity evaluation of formulations, such as tablets, capsules, and injections, most sample solutions to be tested are aqueous solutions. Therefore, a reversed-phase mode is favorable for these samples. Against the background in the pharmaceutical analysis, recently reversed-phase polysaccharide based CSPs have been developed and have become commercially available. 9, 10 The development of high-performance (high theoretical plate number (N), low theoretical plate height (H)), highly selective, and highly sensitive (low detection limit) systems has progressed in HPLC investigations. For high performance, smaller particle sizes of the packing materials give a smaller H value, according to the van Deemter equation. 11 In 2004, an ultra high-pressure HPLC system (UHPLC) with smaller particle packing materials (< 2 μm) was introduced in the market, based on the above conception.
core-shell particles, appeared on the stage. 13 Core-shell particles enable high-performance separation with lower column pressure drops, compared with the smaller totally porous particle packing materials previously employed in UHPLC. This column has drawn attention in recent UHPLC analysis. [14] [15] [16] Under a trend of using smaller particle packing materials, columns for chiral HPLC having a small particle size (3 μm) have become commercially available. 9, 10 In this paper, the authors describe the high-performance enantiomer separation of five nonsteroidal anti-inflammatory drugs (NSAIDs), which are included in The Japanese Pharmacopoeia 16th edition (JP16), employing four kinds of 3 μm reversed-phase CSPs (AD-3R, AS-3R, OD-3R and OJ-3R). 17 Only naproxen (NX) has been used as a single enantiomer (S-form, active form) in the clinical field (JP16); 18 therefore, the optical purity testing method of NX was developed by the reversed-phase CSPs. The developed method was applied to the optical purity testing of NX active pharmaceutical ingredients (APIs) and its formulations (tablet and capsule). Normal phase separation with two CSPs (AD-H and OD-H) and capillary electrophoretic (CE) separation were also investigated for five NSAIDs enantiomers to discuss the enantioselectivity.
Experimental

Reagents and chemicals
An active form of NX, the S(+)-form, was obtained from Wako Pure Chemicals (Tokyo, Japan) and Mitsubishi Tanabe Pharmaceuticals (Osaka, Japan), non-active form, R(-)-form of NX was purchased from Aldrich (St. Louis, MO). Flurbiprofen (FP), ketoprofen (KP), ibuprofen (IB), and pranoprofen (PP), all racemic compounds, were purchased from Wako Pure Chemicals. R(-)-forms of KP and IB obtained from LKT Lab (St. Paul, MN) and Aldrich were used for determining the elution order of the R-and S-forms.
As NX formulations, a 100-mg tablet and a 300-mg capsule obtained from Mitsubishi Tanabe Pharmaceuticals were used. The chemical structures of NSAIDs, described in JP16, are shown in Fig. 1 . Only NX is included as an active form, S(+)-form, and the others are all racemic drugs in JP16.
Uracil as a to marker, methyl p-hydroxybenzoate (Me), ethyl p-hyrdoxybenzoate (Et), isopropyl p-hydroxybenzoate (iPr), n-propyl p-hydroxybenzoate (nPr), and n-butyl p-hydroxybenzoate (Bu), all of the reagent grade, were purchased from Wako. Amicol 5L (dextrin) was gifted from Nichiden Kagaku (Osaka, Japan), and used for CE separation as it is.
Acetonitrile (ACN), methanol (MeOH) and n-hexane of HPLC grade were from Wako. Acetone, acetic acid, phosphoric acid (85%), potassium dihydrogenphosphate, sodium hydroxide, sodium perchlorate of analytical reagent grade, and 0.1 mol/L perchloric acid for non-aqueous titration were from Wako. The water used was purified by an ElixUV (Millipore, Tokyo, Japan).
HPLC apparatus and chiral columns
The HPLC apparatus used for investigating the enantioselectivity was a Shimadzu LC-20AD pump and a Shimadzu SPD-20A detector (set at 254 or 210 nm) (Kyoto, Japan).
The HPLC analysis (column temperature) was performed at room temperature controlled at 25 C. A constant volume (2 -5 μL) of the sample solution was injected manually through a Rheodyne 7725i injector (20 μL loop) and a Hamilton micro-syringe (25 μL). The mobile phase employed for reversed-phase HPLC was a mixture of a 0.05 mol/L phosphate buffer solution (at specified pH) or water, and an organic solvent (ACN or MeOH). The pH of the buffer solution was adjusted by a Mettler Seveneasy pH meter (Greifensee, Switzerland).
Apart from the HPLC apparatus mentioned above, a Prominense HPLC system (Shimadzu) was used for optimization of the HPLC conditions and a content uniformity test of the NX formulation. The system is composed of an LC-20AB pump, an SIL-20AC auto-sampler, an SPD-M20A photodiode array (PDA) detector with an LCsolution software, a CBM-20A system controller, a DGU-20A3 degasser, and a CTO-20A column oven.
Four kinds of 3 μm reversed-phase chiral columns (CHIRALPAK AD-3R, CHIRALPAK AS-3R, CHIRALCEL OD-3R, and CHIRALCEL OJ-3R; all are 3 μm, 4.6 mm i.d. × 15 cm, Daicel, Japan) were employed for the enantiomer separation of five NSAIDs. These types (i.e., AD, AS, OD, and OJ) of columns were most successfully used for enantiomer separations in the published papers in 2012. 7 To compare the enentioselectivity, normal-phase chiral columns, CHIRALPAK AD-H and CHIRALCEL OD-H (5 μm, 4.6 mm i.d. × 25 cm; Daicel, Japan) were used. These chiral columns are all of the polysaccharide type CSPs using amylose or cellulose as a chiral moiety. For the analysis of formulations, a pre-column (4.6 mm i.d. × 1.5 cm) was attached before the analytical column. Phenomenex Gemini NX5u C18 (5 μm, 4.6 mm i.d. × 15 cm; Shimadzu, Japan) was also employed for comparing the hydrophobicity.
UV/VIS and CE apparatus
The determination of the UV/VIS spectra of samples was performed by UV-2550 with UVProve2.31 software (Shimadzu, Japan). The CE apparatus used was the P/ACE MDQ system with 32 Karat software (Beckman, IN).
Enantiomer separation by HPLC
Sample solutions of racemic NSAIDs were prepared with MeOH at a concentration of approximately 1 mg/mL. For NX, a sample solution was prepared through mixing the active S(+)-form and the minor enantiomer R(-)-form at a ratio of approximately 1:1. A solution of a paraben mixture was also prepared by combining each 10 mL of a 100 mg/100 mL MeOH solution of uracil, Me paraben, Et paraben, iPr paraben, nPr paraben, and Bu paraben to a 100-mL volumetric flask. Then, water was added to the volume (10 mg each/100 mL). Uracil was used as a to marker substance, because it was not retained under the applied HPLC conditions. HPLC separations of enantiomers of five NSAIDs and a mixture of paraben were investigated by employing four kinds of the 3 μm reversed-phase chiral columns mentioned above (AD-3R, AS-3R, OD-3R, and OJ-3R) under the following conditions: column temperature, 25 C (room temperature); flow rate, 1.0 mL/min; detection, UV 254 nm (210 nm for IB). Two types of a mobile phase were employed: one was a mixture of a 0.05 mol/L phosphate buffer solution (pH 2.5) and ACN (3:2), and the other was a mixture of water and ACN (3:2). A constant volume (2 -5 μL) of the sample solution was injected manually through a Rheodyne 7725i injector (20 μL loop). For a comparison, chiral columns for normal-phase (AD-H and OD-H) were also used for the enantiomer separation of five NSAIDs. A mobile phase of n-hexane/acetone/acetic acid (80:20:1) was used. The elution order of enantiomers of NX, IB and KP was determined by analyzing a sample solution (NX, a mixture of the S-form and the R-form (1:1); IB and KP are racemic compounds) added the authentic R(-)-form enantiomer.
Enantiomer separation by CE
CE separation was performed with an i.d. 50 μm capillary tube (60 cm length; effective length, 50 cm) under the following conditions: capillary temperature, 25 C; applied voltage, +30 kV; detection, 200 or 254 nm (by a photo diode array detector). Sample solutions (approximately 1 mg/mL MeOH) were diluted by water to one fifth and introduced into the capillary from the positive end by a pressure mode (0.5 psi, 5 s). The buffers used were 0.02 mol/L phosphate buffer (at a specified pH, typically 7.0). After the addition of a chiral selector to the buffer, the solution was filtered with a membrane filter of 0.45 μm pore size (Life Sciences, Tokyo, Japan) and degassed by an ultrasonic bath (AU-16C, Tokyo-rika, Tokyo, Japan) before use. Buffer of pH 7.0 was prepared by the addition of a 0.1 mol/L NaOH solution to a 0.02 mol/L potassium dihydrogen phosphate hydrate solution. Amycol 5 L (dextrin) was used as a chiral selector in this study. The capillary was rinsed with a 1.0 mol/L NaOH solution for 5 min, followed by water for 5 min, and finally with a running buffer for 15 min before the first run.
Purity testing of NX APIs and its formulations by reversed-phase chiral HPLC
Approximately 20 mg of NX API was dissolved in 20 mL of the mobile phase and used as the sample solution for purity testing. For formulations, samples were powdered, and an equivalence to approximately 100 mg of NX API was weighed to a 100-mL volumetric flask. An extract solvent (0.05 mol/L phosphate buffer (pH 2.5)/MeOH = 1:1) was added to the volume. After shaking, the solution was filtered with a 0.45-μm membrane filter. After discarding 2 -3 mL of the first filtrate, the following filtrate was used as the sample solution; 10 μL of the solution was introduced to HPLC under the conditions mentioned below, and the test was performed according to the JP16 General Tests <2.01>.
Content uniformity test of formulations by reversed-phase chiral HPLC
One tablet (NX 100 mg) was put into a 100-mL volumetric flask; then, 70 mL of the extract solution and exactly 5 mL of the internal standard solution was added to the flask. To disintegrate the tablet well, an ultrasonic wave was added to the flask by the ultrasonic bath for approximately 15 min. Then, the extract solution was added to the volume. After shaking the flask well, the solution was filtered with a membrane filter of 0.45 μm and the filtrate was used as the sample solution for the content uniformity test. Separately, approximately 0.1 g of NX API for an assay was weighed accurately into a 100-mL volumetric flask, and added the extraction solution to the volume. This solution was used as the standard solution for the content uniformity test. Each 10 μL of the sample solution and the standard solution was injected to HPLC under the conditions mentioned below, and the content uniformity test was performed according to the JP16 General Tests <2.01>.
The HPLC conditions are as follows: detector, UV/VIS detector (wavelength, 254 nm); column, CHIRALPAK AS-3R (3 μm, 4.6 mm i.d. × 15 cm length); column temperature, a constant temperature of around 40 C; mobile phase, 0.05 mol/L phosphate buffer (pH 2.5)/ACN = 3:2; flow rate, 1.0 mL/min; internal standard (IS) solution, 0.4 g of nPr paraben dissolved in 100 mL of MeOH.
Results and Discussion
UV spectra of NSAIDs and separation of paraben by reversed-phase chiral HPLC
The UV spectra of five NSAIDs were measured according to each monograph in JP16, only changing the specified solvent to the mobile phase employed in this study. Except for IB, the NSAIDs in Fig. 1 showed λmax at around 254 nm (data not shown). Therefore, a detection wavelength of 254 nm for NSAIDs was selected, except for IB; 210 nm was used for the detection of IB.
Before investigating the enantioselectivity of four reversed-phase chiral columns for NSAIDs, the hydrophobicity of those columns was investigated by analyzing a mixture of paraben, which is usually used as a text mixture for the reversed-phase HPLC column. An example of separating five parabens by the AS-3R column under the following conditions: a mobile phase of 40% ACN, flow rate of 1.0 mL/min and column temperature of 40 C, is shown in Fig. 2(A) . Resolution (Rs) values between iPr and nPr paraben obtained by the four columns are summarized in Table 1 , where results in the enantiomer separation of NSAIDs are also shown. An Rs of around 3 and an N of around 15000 (H around 10 μm) were obtained for the separation of iPr and nPr paraben. Usually these two parabens (iPr and nPr) elute closely in the conventional C18 column. The retention times of those were 7.7 and 8.2 min, and the Rs value was 1.34, under the following conditions: a column of conventional C18 (Phenomenex Gemini NX5u C18, 5 μm, 4.6 mm × 150 mm), a mobile phase of 40% ACN, a flow rate of 1.0 mL/min and a column temperature of 25 C. Reversed-phase chiral columns gave larger Rs values for the separation of iPr and nPr parabens; these are structural isomers compared with the conventional C18 column. This indicates the superior selectivity of the chiral columns not only the enantiomers, but also the structural isomers. Judging from the almost same retention times of parabens under the same conditions (i.e., 40% ACN), the hydrophobicity values in both four reversed-phase chiral columns and the conventional C18 column seem to be the same.
Enantiomer separation of NSAIDs by reversed-phase chiral HPLC
Direct HPLC enantiomer separations of NX and its related compounds have been reported previously. [19] [20] [21] [22] [23] Proteins such as α1AGP, human serum albumin (HSA) and bovine serum albumin (BSA) immobilized CSPs have been successfully used for the enantiomer separation of NX under the reversed-phase mode. 19, 20 However, the theoretical plate number (N) of these protein-based CSPs was very low, leading to a low detection limit. Some polysaccharide-based CSPs were also found to be useful for the enantiomer separation of NX and its related compounds under the normal-phase mode. 21, 22 As mentioned above, the normal phase is not suitable for pharmaceutical analysis. Chiral mobile phase HPLC in nano-liquid chromatography has been reported. 23 CDs were added to reversed-phase C18 columns (100 μm i.d. × 10 cm). Chiral mobile phase HPLC requires high consumptions of expensive chiral additives in the usual size columns (4.6 mm i.d. × 15 cm). Therefore, optical purity testing method of NX was developed by reversed-phase polysaccharide based CSPs with a 3-μm particle size to expect high performance.
The results in enantiomer separation by four revered-phase chiral columns under certain conditions (a mobile phase of 40% ACN in a buffer of pH 2.5 (A) or water (B), a flow rate of 1.0 mL/min and a column temperature of 25 C) are summarized in Table 1 . Here, tR1 is the retention time of the first eluted enantiomer and tR2 is the retention time of the secondary eluted enantiomer. If the enantiomer separation is unsuccessful, the retention time of the peak (one peak) appears at tR1. For NX and IB, the elution order of enantiomers (R-form and S-form) was determined by the authentic sample.
Except for KP, enantiomer separation was successful for NX, FB, IB and PP by employing one of the four chiral columns. Under the employed conditions (ACN 40%), all enantiomers eluted within 15 min, and the Rs values were all larger than 1.5 (baseline separation, according to JP16), except for PP. The baseline separation of enantiomers of PP could be obtained by reducing the ACN%. The results demonstrate the excellent enanatioselectivity of these reversed-phase chiral columns for propionic acid NSAIDs.
Compared with normal-phase separation, reversed-phase separation has many advantages for the analysis of formulations, biological samples such as serum, urine etc.
Next, the relationship between ACN% and the retention times of the enantiomers of NX in the AS-3R column at 40 C was investigated. The results are shown in Fig. 3 . An example concerning the separation of enantiomers of NX at a column temperature of 40 C is shown in Fig. 2(B) . Two enantiomers eluted within around 6 min with Rs 2.55 and N values of around 12000. The Rs values at ACN 20 and 40% were 3.82 and 1.20, respectively (ACN 40%, 2.55). The results indicate the main interaction of the column for retention is hydrophobicity. The elution order of five NSAIDs in the conventional C18 column was PP > KP > NX > FB > IB (data not shown). This order corresponded well to the data given in Table 1 . From these results, it was found that the concentration of an organic solvent in a reversed-phase chiral column can be estimated from the result in the conventional reversed-phase analysis with a C18 column. For a mobile phase, a buffer (pH 2.5) was better than water (simple reversed-phase mobile phase, around pH 7.0), judging from the peak shape (tailing) and reproducibility of the retention time in using the mobile phase (B). In the following study, a mobile phase (A) was adopted. Further a non-ionic form of NSAIDs seems to be favorable for enantiomer separation by these columns, because of no improvement of Rs with a decrease of ACN% when using the mobile phase (B) (discussed below).
Among five NSAIDs, enantiomers of FB were separated by all reversed-phase chiral columns. A fluorine substituent at meta-position seems to contribute to the effective enantiorecognition of FB. On the other hand, the enantiomer separation of KP was unsuccessful by employing the four chiral columns. The reason may be the flexible structure (diphenylketo) of KP, compared with the others. Enantiomers of NX were separated by AD-3R and AS-3R columns. OD-3R and OJ-3R were not successful. This may indicate that the polysaccharides used for AD-3R and AS-3R, amylase, contribute to the effective enantiorecognition of NX. The chemical structures (chiral moiety) of the four reversed-phase columns are shown in Fig. 4 . "A" in AD-3R and AS-3R means amylase, "O" in OD-3R and OJ-3R indicates cellulose. The two-letter code used for the chiral column means that the first letter is the type of polysaccharide; the second letter is the type of chiral moiety.
Enantiomer separation of NSAIDs by normal phase chiral HPLC
To investigate the enantioselectivity of the polysaccharide-type CSPs for five NSAIDs, two normal-phase CSPs, AD-H and OD-H, were employed for the enantiomer separation of five NSAIDs. The results are given in Table 2 . Except for IB, the others were enantioseparated by normal-phase chiral HPLC. Especially, enantiomsers of KP that were not separated by the reversed-phase chiral HPLC were well separated (Rs, 6.45) by the AD-H column. The keto (C=O) structure of KP may contribute to the interaction with the CSP through hydrogen bonding under the normal mobile phase (non aqueous).
Enantiomers of NX were separated by AD-type columns, and the elution order of the R-form and the S-form was reversed between the AD-3R and AD-H columns. This result follows the theory of adsorption (normal phase partition) and reversed-phase partition. Interestingly, the elution order of the R-form and the S-form was also reversed between AD-H and OD-H; both are chiral columns for the normal phase. The difference concerning the two columns is the type of polysaccharide.
Enantiomer separation of NSAIDs by CE with dextrin
Other than HPLC separation, CE enantiomer separation was investigated. Successful CE enantiomer separation of NSAIDs has been reported. [24] [25] [26] In CE separation, typically chiral selectors, such as CDs, proteins and chiral surfactants, are added to the running buffers. [26] [27] [28] [29] Among various chiral selectors, successful enantiomer separations of some NSAIDs have been reported by employing dextrin as a chiral selector. 19, 20 The CE enantiomer separation of NSAIDs was investigated by employing dextrin. The results are summarized in Table 3 ; 10% of a dextrin solution (pH 7.0) was used as a buffer. Without dextrin, the peak of enantiomers having the negative charge at pH 7.0, appeared as a single peak after the signal peak of electroosmotic flow (EOF). Three of five NSAIDs were enantioseparated by the CE method with dextrin. Under the CE conditions, a carboxylic group of NSAIDs is dissociated (pKa of NX, ca. 4.7); therefore, its electrophretic direction is toward the positive end (injection side). However, a strong EOF toward the negative end overcomes its electrophretic velocity, resulting in migration toward the negative end. This means that the faster migrated enantiomer interacts strongly with the dextrin, which has no charge and migrates with the EOF. In the case of NX, the migration order was R-form > S-form, meaning a stronger interaction of the R-form with the dextrin. This is reversed to the result given in Table 1 . In reversed-phase HPLC, amylase type polysaccharide CSPs (AD-3R and AS-3R) interacted stronger with the S-form. Further, in the normal-phase HPLC (Table 2) , the elution order differed between AD-H and OD-H. In conclusion, the predicition of the successful enantiomer separation and elution order of R/S-forms seems to be difficult. The efficient chiral column for enantioseparation will still be selected by the trial and error method while refereeing to application data. 
Optimization of the enantiomer separation of NX by the AS-3R column
In the optical purity testing of pharmaceuticals by separation analysis, the minor enantiomer should be migrated before the main peak due to tailing of the large main peak. For synthetic chiral columns, the elution order can be manipulated by changing the chirality of the chiral moiety introduced to the packing materials.
However, this is difficult for polysaccharide-type CSPs, because the chirality is dependent on the natural product. Among five NSAIDs investigated, only NX has been used as a chiral drug, as shown in JP16 (Fig. 1) . Therefore, in a following investigation, the optical purity testing of NX (active form, S-form) was investigated. Fortunately, the minor enantiomer R-form eluted faster than the active S-form in the reversed-phase chiral columns, as can be seen in Table 1 . The AS-3R column was selected.
The HPLC conditions for the separation of NX enantiomers were optimized by changing ACN% (from 20 to 60%) and the buffer pH (from 2.5 to 5.5). The effect of ACN% in the buffer (pH 2.5) is shown in Fig. 3 . ACN 40% (retention time within 10 min and Rs 2.55) was selected. As for the buffer pH, various pH buffers were employed at the ACN 40% mobile phase. The results are summarized in Table 4 . With an increase in the buffer pH, the retention times of NX enantiomers decreased. Because pKa of NX is 4.70, the pH is above around 5, and a carboxylic acid of NX is dissociated and NX becomes a hydrophilic compound, leading to a low retention, as shown in Table 4 . To improve the separation, a lower ACN% (20%) was used for a mobile phase of the buffer (pH 5.5). However, the peak shape (N value) and the selectivity (Rs) of the enantiomers were not good. This means that the non-ionic form (molecular form) is superior to the ionic form (dissociated form) concerning the enantioselectivity.
Further, the species of the buffer sometimes have some influence on the enantioselectivity. 9,10 A 0.05 mol/L perchlorate buffer solution of pH 2.5 was employed for the NX enantiomers. No difference between a chromatogram obtained from the phosphate buffer of pH 2.5/ACN 40% and that in the perchlorate buffer of pH 2.5/ACN 40% was observed. No effect of the bulky buffer was found on the enantiomer separation of the NX enantiomers.
To consider the column pressure drops, ACN was used as the organic solvent mentioned above. Other than ACN, MeOH and tetrahydrofuran (THF) are often used in revered-phase HPLC.
Therefore, MeOH was employed as an organic solvent to compare the enantioselectivity.
The separation of NX enantiomers under certain conditions (mobile phase of 0.05 mol/L phosphate buffer (pH 2.5)/MeOH (2:3); column temperature of 40 C) is shown in Fig. 2(C) . A Rs value of 0.67 with retention times of the enantiomers being around 10 min was obtained. ACN showed higher enantioselectivity and better peak shape (higher N value) compared with MeOH. Therefore, ACN was selected as an organic solvent. According to the column brochure, 9 the use of THF is prohibited, although THF showed excellent selectivity for some compounds in reveredphase HPLC. 30 Finally the effect of the column temperature on the separation was investigated at 25 and 40 C. The Rs value was 3.01 at 25 C with retention times of around 7.5 min. With an increase of the retention times, the Rs value was slightly improved from 2.55 to 3.01.
However, 40 C was selected in considering the reproducibility of the retention time (controlled by the usual column oven). The final optimized HPLC conditions for the NX enantiomers are shown in the Experimental section.
Application to the optical purity testing of NX APIs and its formulations
A purity test (usually called "related substances" test), including an optical purity evaluation, of NX APIs and its formulations (tablet and capsule) was performed by the method mentioned above. Two APIs obtained from Mitsubishi Tanabe and Wako (each one lot), and two formulations, NX tablet 100 mg and NX capsule 300 mg from Mitsubishi Tanabe, were tested. The results are summarized in Table 5 . Typical chromatograms in the test are shown in Fig. 5 . The R-form was identified by an analysis of the sample solution spiked authentic R-form (i.e., co-chromatography). A relatively large impurity (0.2 -0.8%, R-form) was not detected in the usual reversed-phase HPLC analysis of the sample solution. The calibration curve between the 0.1 -5.0% R-form added to the S-form was investigated for validation. The calibration curve gave a straight line with R 2 0.9999 (figure not shown). In the test, peaks above 0.01% were monitored.
As given in Table 5 , the same impurity profile was observed in one API and two formulations obtained from Mitsubishi Tanabe; on the other hand, a different impurity of 0.3% was detected between the minor enantiomer (R-form) and the major enantiomer (S-form) from one API obtained from Wako (of biochemical grade). This indicates the different synthetic process of API between Mitsubishi Tanabe and Wako. 0.2 -0.8% of the R-form and six impurities (four before the pain peak and two after the main peak) were detected in four samples, as shown in Table 5 . According to the monograph of NX API in JP16, a thin-layer chromatography (TLC) method with the specification of not more than 0.2% is adopted as a purity test. Also optical purity is regulated by the optical rotation range of +63.0 -+68.5 . Its tolerance level seems to be several %, judged from the sensitivity of the optical rotation method. Although the validation study is not sufficient, one API from Wako (for biochemical use) was out of the specifications of JP16.
Application to the content uniformity test of NX formulations
A content uniformity test of a NX tablet 100 mg was also performed according to JP16, employing the method mentioned above; nPr paraben was used as an internal substance in this method. The results are given in Table 6 . Assay results of 98.6 -100.9%, a relative standard deviation (RDS) of 0.79%, and an acceptance value of 1.90% were obtained. The NX tablet 100 mg passed the test, because of the lower acceptance value (1.90%) below the criteria of 15.0%. Typical chromatograms in the test are shown in Fig. 6 .
Conclusions
High-performance enantiomer separation of five NSAIDs, except for KP, was successfully performed by employing four kinds of 3 μm reversed-phase chiral columns (AD-3R, AS-3R, OD-3R and OJ-3R). Among five NSAIDs, only NX has been used as a single enantiomer (S-form, active form) in the clinical field. Therefore, an optical purity testing method of NX was developed by using the AS-3R column. An Rs of 2.55 was obtained for the NX enantiomers within approximately 6 min. The performance is better than that by 5 μm reversed-phase chiral column (AS-RH). 9 Further, optical purity testing including normal (not chiral) impurities was successful when using the developed method. The minor enantiomer (R-form, inactive form) at a level of 0.21 -0.78%, and several other normal (not chiral) impurities at a level of 0.01 -0.3% were simultaneously separated and determined.
The content uniformity test of the NX tablet according to JP16 was also successfully performed by the method; 3 μm reversed-phase chiral columns were found to be effective for these tests. However, the development of a novel chiral column is still ongoing. 31, 32 Markedly high-performance enantiomer separation could be obtained with chiral core-shell particle columns at around 3 μm particle size. Therefore, the development of chiral core-shell columns is highly expected. 
